Savant Capital, LLC Xeris Biopharma Holdings, Inc. Transaction History
Savant Capital, LLC
- $12.3 Billion
- Q4 2024
A detailed history of Savant Capital, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 22,116 shares of XERS stock, worth $128,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,116
Previous 22,115
-0.0%
Holding current value
$128,493
Previous $63,000
17.46%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$60 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$45.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$19.5 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$19.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$16.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $790M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...